Rajeev Saggar
Director Técnico/Científico/I+D en LIQUIDIA CORPORATION .
Fortuna: 3 M $ al 30/04/2024
Cargos activos de Rajeev Saggar
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
LIQUIDIA CORPORATION | Director Técnico/Científico/I+D | 18/07/2022 | - |
Historial de carrera de Rajeev Saggar
Antiguos cargos conocidos de Rajeev Saggar.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Director Técnico/Científico/I+D | 01/09/2021 | 01/07/2022 |
The Banner-University Medical Center | Corporate Officer/Principal | - | - |
Formación de Rajeev Saggar.
University of California, Irvine | Doctorate Degree |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectorial
Consumer Services | 3 |
Health Technology | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
LIQUIDIA CORPORATION | Health Technology |
Empresas privadas | 1 |
---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Rajeev Saggar
- Experiencia